MedTrace Logo

Early Identification and Severity Prediction of Acute Respiratory Infectious Disease

NCT04955756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2022-05-12

No results posted yet for this study

Summary

Early identification and Severity prediction of Acute Respiratory infectious disease has become a top priority for clinicians at department of infectious and respiratory diseases after COVID-19 broke out. This is a multicenter, prospective, and randomized study, which aims to figure out the best way of early identification and severity prediction of acute respiratory infectious diseases. Patients with suspected acute respiratory infectious diseases will be enrolled into this study and received two different diagnostic pathways.

Conditions

  • Acute Respiratory Infection
  • Severe Pneumonia
  • Next Generation Sequencing
  • Multiplex PCR

Interventions

DIAGNOSTIC_TEST

mNGS

Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment.

DIAGNOSTIC_TEST

Multiplex PCR

Participants will be randomized to receive mNGS or multiplex PCR for diagnosis at enrollment.

Sponsors & Collaborators

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Wenhong Zhang, Prof · Department of Infectious disease, Huashan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-04
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955756 on ClinicalTrials.gov